Thymopentin Completed Phase N/A Trials for Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00002051Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection
NCT00002050A Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients
NCT00002049Double Blind Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients
NCT00002066Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection
NCT00002289The Effects of Thymopentin on HIV Infectivity of Blood Cells and Semen in HIV-Infected Patients